Heeju Ryu1,2, Hoyong Lim1, Garam Choi1,2, Young-Jun Park1,2, Minkyoung Cho1, Hyeongjin Na1,2, Chul Won Ahn2,3, Young Chul Kim2,3, Wan-Uk Kim4, Sang-Hak Lee5 and Yeonseok Chung1,2*
1Laboratory of Immune Regulation, Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. 2BK21 Plus program, College of Pharmacy, Seoul National University, Seoul, Republic of Korea. 3Laboratory of Toxicology, College of Pharmacy, Seoul National University, Seoul, Republic of Korea. 4Center for Integrative Rheumatoid Transcriptomics and Dynamics, The Catholic University of Korea, Seoul, Republic of Korea. 5Division of Cardiology, Department of Internal Medicine, Severance Hospital, College of Medicine, Yonsei University, Seoul, Republic of Korea.
*Correspondence to Yeonseok Chung